Hologic Inc. (HOLX) reported results for Q1 2026.
Cost of goods sold declined notably to $420.4 million (down 27.6% year-over-year). Despite improvements in gross and operating profit, net income and EPS fell versus the prior year.
Both top-line and per-share results came in below consensus: revenue missed the estimate of $1.09 billion, and EPS missed the estimate of $1.11 per share. The revenue shortfall was about $43.8 million, and EPS missed by roughly $0.32 per share.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Hologic Inc. Insider Trading Activity
Hologic Inc. insiders have traded $HOLX stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $HOLX stock by insiders over the last 6 months:
- STEPHEN P MACMILLAN (Chairman, President and CEO) has made 0 purchases and 3 sales selling 138,358 shares for an estimated $9,266,117.
- CHRISTIANA STAMOULIS sold 7,402 shares for an estimated $540,864
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Hologic Inc. Hedge Fund Activity
We have seen 342 institutional investors add shares of Hologic Inc. stock to their portfolio, and 336 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORDEA INVESTMENT MANAGEMENT AB removed 2,809,275 shares (-99.2%) from their portfolio in Q4 2025, for an estimated $209,262,894
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,533,649 shares (-10.5%) from their portfolio in Q3 2025, for an estimated $170,995,971
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 2,131,526 shares (-99.5%) from their portfolio in Q4 2025, for an estimated $158,777,371
- MILLENNIUM MANAGEMENT LLC added 1,949,741 shares (+201.3%) to their portfolio in Q3 2025, for an estimated $131,588,020
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,628,005 shares (+62.7%) to their portfolio in Q3 2025, for an estimated $109,874,057
- MORGAN STANLEY added 1,552,180 shares (+65.8%) to their portfolio in Q3 2025, for an estimated $104,756,628
- POINT72 ASSET MANAGEMENT, L.P. added 1,386,104 shares (+inf%) to their portfolio in Q3 2025, for an estimated $93,548,158
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Hologic Inc. Government Contracts
We have seen $21,581,254 of award payments to $HOLX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- 8511320806!ANNUAL MAINTENANCE: $2,915,365
- MODALITY: XR MAMMO PURCHASE ORDER: 590B49006 LOCATION: VAMC HAMPTON, VA REQUIREMENT: 3DIMENSIONS MAMMOGRAPHY S: $952,000
- 756B45004 XR MAMMO VAMC EL PASO TX MAR FY24 CONSOLIDATION: $799,090
- MODALITY: XR MAMMO PURCHASE ORDER: 590B49005 LOCATION: VAMC HAMPTON, VA REQUIREMENT: 3DIMENSIONS MAMMOGRAPHY S: $598,150
- PANTHER REAGENTS AND SUPPLIES: $573,600
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Hologic Inc. Price Targets
Multiple analysts have issued price targets for $HOLX recently. We have seen 8 analysts offer price targets for $HOLX in the last 6 months, with a median target of $78.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $78.0 on 01/05/2026
- Tejas Savant from Morgan Stanley set a target price of $76.0 on 11/11/2025
- Anthony Petrone from Mizuho set a target price of $78.0 on 10/23/2025
- Casey Woodring from JP Morgan set a target price of $78.0 on 10/22/2025
- Mason Carrico from Stephens & Co. set a target price of $76.0 on 10/22/2025
- Puneet Souda from Leerink Partners set a target price of $78.0 on 10/21/2025
- David Toung from Argus Research set a target price of $90.0 on 09/19/2025
